CIK 0000010795
- Large accelerated filer
BECTON DICKINSON & CO
Sign in to watch- Ticker
- BDX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 220760120
- Phone
- +1 201-847-6800
- Business address
- ONE BECTON DR, FRANKLIN LAKES, NJ, 07417-1880
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $688,650
- in 4 filings, $689K under 10b5-1 plans
Net −$688,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-26 | Ezell Antoine C EVP, President NA & CMO | Grant or award · Stock Appreciation Rights | +5,298 | 5,298 | ||
| 2023-11-26 | Goette Roland EVP and President EMEA | Grant or award | +582 | 15,995 | ||
| 2023-11-26 | Goette Roland EVP and President EMEA | Grant or award | +2,608 | 18,603 | ||
| 2023-11-26 | Goette Roland EVP and President EMEA | Shares withheld for taxes | −213 | 18,390 | ||
| 2023-11-26 | Goette Roland EVP and President EMEA | Grant or award · Stock Appreciation Rights | +3,225 | 3,225 | ||
| 2023-11-20 | Neal Shana Carol EVP and Chief People Officer | Exercise or conversion 10b5-1 | +110 | 16,941 | ||
| 2023-11-20 | Neal Shana Carol EVP and Chief People Officer | Shares withheld for taxes 10b5-1 | −31 | 16,910 | ||
| 2023-11-20 | Neal Shana Carol EVP and Chief People Officer | Exercise or conversion · Rights to Common Stock Under Deferred Compensation Plan 10b5-1 | −110 | 448 | ||
| 2023-11-16 | Goette Roland EVP and President, EMEA | Returned to the company | −2,233 | $235.07 | $525K | 14,931 |
| 2023-11-16 | Goette Roland EVP and President, EMEA | Exercise or conversion | +3,544 | $107.12 | $380K | 17,164 |
| 2023-11-16 | Goette Roland EVP and President, EMEA | Returned to the company | −1,751 | $235.07 | $412K | 15,413 |
| 2023-11-16 | Goette Roland EVP and President, EMEA | Exercise or conversion · Stock Appreciation Rights | −3,544 | 0 | ||
| 2023-11-03 | Byington Carrie L Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +118 | $252.78 | $30K | 910 |
| 2023-11-03 | Jones Christopher Ian Montague Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +118 | $252.78 | $30K | 9,624 |
| 2023-09-07 | DelOrefice Christopher EVP & Chief Financial Officer | Shares withheld for taxes | −601 | 10,999 | ||
| 2023-09-05 | Byrd Richard EVP & President Interventional | Sale 10b5-1 | −459 | $274.48 | $126K | 3,444 |
| 2023-09-01 | Byrd Richard EVP & President Interventional | Shares withheld for taxes | −216 | 3,903 | ||
| 2023-09-01 | DelOrefice Christopher EVP & Chief Financial Officer | Shares withheld for taxes | −353 | 11,600 | ||
| 2023-08-28 | Fraser Claire Director | Sale | −848 | $281.66 | $239K | 21,608 |
| 2023-08-11 | Hickey David EVP & President, Life Sciences | Exercise or conversion 10b5-1 | +3,883 | $132.54 | $515K | 9,030 |
Page 15 of 28 · 548 trades